Is tendonitis reportable under Reporting of Injuries, Diseases and Dangerous Occurrences Regulations (RIDDOR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Tendonitis is not reportable under the Reporting of Injuries, Diseases and Dangerous Occurrences Regulations (RIDDOR) in the UK. RIDDOR specifically requires reporting of certain work-related injuries, occupational diseases, dangerous occurrences, and incidents that result in more than seven days away from work. While tendonitis can be work-related and may develop due to repetitive movements, overexertion, or poor ergonomics in the workplace, it is not included in RIDDOR's list of reportable diseases. The reportable occupational diseases under RIDDOR are more specific and include conditions like certain poisonings, some skin diseases, lung diseases, infections, and hand-arm vibration syndrome 1. Employers should still document cases of work-related tendonitis for their internal occupational health records and take preventive measures to address the underlying causes, even though formal RIDDOR reporting is not required. If tendonitis leads to an absence from work of more than seven consecutive days, then the absence itself would need to be reported under RIDDOR, but not the condition of tendonitis specifically.

Some key points to consider:

  • Tendonitis, or tendinopathy, is a common condition that can be caused by work-related activities, but it is not specifically listed as a reportable disease under RIDDOR 2.
  • The treatment of tendonitis typically involves a combination of rest, physical therapy, and pain management, and may include the use of platelet-rich plasma (PRP) injections or other therapies 3, 4.
  • While there is some evidence to support the use of PRP injections for certain types of tendonitis, such as patellar tendinopathy, the evidence is not yet conclusive and more research is needed to fully understand the effectiveness of this treatment 5.
  • In terms of reporting, employers should prioritize documenting cases of work-related tendonitis and taking steps to prevent future incidents, even if formal RIDDOR reporting is not required.

Overall, the key takeaway is that tendonitis is not reportable under RIDDOR, but employers should still take steps to document and prevent work-related cases.

References

Research

Management of Chronic Tendon Injuries.

American family physician, 2019

Research

Patellar Tendinopathy.

Sports health, 2015

Research

Conservative Treatment of Tendon Injuries.

American journal of physical medicine & rehabilitation, 2020

Research

An exercise-based physical therapy program for patients with patellar tendinopathy after platelet-rich plasma injection.

Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine, 2013

Research

Current Clinical Recommendations for Use of Platelet-Rich Plasma.

Current reviews in musculoskeletal medicine, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.